Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression. [electronic resource]
Producer: 20200327Description: 169-176.e1 p. digitalISSN:- 1938-0682
- Adult
- Aged
- Aged, 80 and over
- B7-H1 Antigen -- metabolism
- Carcinoma, Renal Cell -- drug therapy
- Disease Progression
- Down-Regulation
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Kidney Neoplasms -- drug therapy
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Phenotype
- Retrospective Studies
- Sunitinib -- administration & dosage
- Survival Analysis
- Treatment Outcome
- Von Hippel-Lindau Tumor Suppressor Protein -- genetics
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.